Coala Life is listed by the Wired as one of the 100 hottest start-ups in Europe.
Clinical performance results are presented on the Digital Health stage at the world's largest cardiology meeting - European Society of Cardiology (ESC) - including results from the Red Heart Study.
Coala Life expands into the US market with office in Irvine, CA, and sales team spread across USA.
Coala partners with Luscii and enters the Dutch market
Coala Life Inc is established on the US market and first team on board. Coala enters the German market in partnership with Arteriomed GmbH.
Microsofts CEO Satya Nadella highlights Coala Life as major game changer in healthcare part of his keynote presentation in Stockholm
Coala Life elected by Valuer.ai as the leading MedTech startup in Sweden.
Coala Life elected by Norrsken as one of the #theimpact100 companies, with goal and passion to solve global challenges.
Coala Life secures A-series funding of total USD 11 million for expansion into the US market.
New research presented confirming the leading clinical accuracy of the Coala Heart Monitor, see here
Coala Life signs commercialisation agreement with Apotek Hjärtat, the largest Pharmacy retailer in Sweden
Coala Heart Monitor is cleared by the FDA, read pressrelease here.
Coala Life is recognized as one of 100 top Global leaders in Digital Health by The Journal of mHealth
Coala introduces new, unique algorithms with advanced P-wave detection and compatibility with Apple Health Records. Read more here.
Performance assessment study presented at American Heart Association 2018, and published in Circulation.
Coala Life elected by research firm PUBLIC as one of the leaders of the digital transformation of public healthcare.
Coala presents at the Health 2.0 conference in Santa Clara, US.
Coala named "Cool Vendor 2018" by Gartner.
Coala attends and presents at the Digital Health Pavilion of ESC 2018, the largest cardiovascular meeting in the world.
Coala Life is recognized by Red Herring as one of Europe's Top-100 start-ups.
Coala Life wins the People's Choice Award of the prestigious 2018 Grand Award of Design.
Publishing of clinical performance data at the 2018 Spring Cardiovascular Spring meeting in Stockholm.
Results from joint-project with Praktikertjänst (the largest private healthcare provider in Sweden) is presented proving a reduction in specialist referrals with almost 40%, with reduced costs and satisfied users as results.
The University Hospital in Lund starts using the Coala Pro for smart and Digital cardiac assessments.
Coala Life wins the Startup World Cup finals in Sweden and heading for the global grand finale in Silicon Valley.
Coala Life signs deal with global life science company Bayer. Read article here.
Coala Life raises additional growth capital and extends the Board.
Coala receives a major grant from the Swedish Governmental agency for Innovation Systems (Vinnova) to further develop Artificial Intelligence to enable early prediction of heart disease.
Coala Life is awarded the prestigious Rising Star Award 2017 at the Swedish American Life Science Summit.
Coala is used in unique new clinical study on stroke patients.
Launch of the Coala Pro, a unique digital solution for caregivers and professional users to enable efficient, high performance yet simple arrhythmia assessments as well as diagnosing and managing patients with AFIB.
Coala Life wins the prestigious eHealthAward 2017, handed over by the Swedish Minister of Health.
The Coala is launched in Sweden and sold online and in retail by LloydsPharmacy in Sweden.
Coala Life is a proud winner and part of "Sweden’s 33 hottest tech companies list 2017".
Coala is CE-approved and Coala Life is ISO 13485 certified.
Coala Life AB is founded after the fourth generation technology platform and analysis algorithms are successfully verified.
Coala research is initiated by Swedish entrepreneurs and physicians with the goal of developing wireless systems for digital monitoring and diagnosing of the heart.